IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Pilotto, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.496
EU - Europa 2.089
AS - Asia 1.638
SA - Sud America 9
OC - Oceania 7
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.247
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.462
CN - Cina 591
SG - Singapore 542
UA - Ucraina 372
IT - Italia 344
DE - Germania 316
HK - Hong Kong 288
FR - Francia 273
RU - Federazione Russa 176
TR - Turchia 165
IE - Irlanda 158
GB - Regno Unito 154
FI - Finlandia 149
CZ - Repubblica Ceca 50
PL - Polonia 27
CA - Canada 24
BE - Belgio 16
SE - Svezia 15
NL - Olanda 13
ID - Indonesia 10
VN - Vietnam 10
IN - India 8
MX - Messico 8
ES - Italia 7
JP - Giappone 7
AU - Australia 6
AT - Austria 5
BR - Brasile 5
EU - Europa 4
IR - Iran 4
PH - Filippine 3
RO - Romania 3
AZ - Azerbaigian 2
EC - Ecuador 2
EG - Egitto 2
GE - Georgia 2
JM - Giamaica 2
MU - Mauritius 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CH - Svizzera 1
EE - Estonia 1
GR - Grecia 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
Totale 9.247
Salva come PNG Salva come JPEG
Città #
Fairfield 884
Woodbridge 575
Singapore 457
Ashburn 449
Houston 383
Seattle 372
Cambridge 327
Jacksonville 314
Wilmington 292
Hong Kong 286
Ann Arbor 261
Princeton 236
Chandler 188
New York 174
Istanbul 164
Dublin 147
Helsinki 117
Dearborn 96
Nanjing 94
Beijing 84
Moscow 70
San Diego 68
Brescia 56
Des Moines 56
Shenyang 48
Milan 41
Nanchang 36
Brno 33
London 32
Shanghai 32
Changsha 31
Boardman 27
Munich 27
Warsaw 26
Jinan 23
Ningbo 22
Hebei 21
Romola 21
San Francisco 21
Los Angeles 20
Lancaster 19
Tianjin 19
Lappeenranta 18
Norwalk 18
Olomouc 17
Toronto 17
Brussels 16
Kunming 14
Verona 14
Zhengzhou 13
Hangzhou 12
Jiaxing 12
Kilburn 12
Dong Ket 10
Guangzhou 9
Jakarta 8
Washington 8
Brindisi 6
Darfo 6
Florence 6
Frankfurt am Main 6
Hefei 6
Orange 6
San Mateo 6
Taizhou 6
Wipperfürth 6
Fuzhou 5
Hounslow 5
Murcia 5
Rome 5
Ancona 4
Augusta 4
Bielefeld 4
Bologna 4
Cascina 4
Ciudad Nezahualcoyotl 4
Cologno Monzese 4
Lanzhou 4
Melbourne 4
Naples 4
Nürnberg 4
Rende 4
Salina Cruz 4
Taiyuan 4
Wandsworth 4
Ardabil 3
Chiswick 3
Falkenstein 3
Falls Church 3
Haikou 3
Pavia 3
Portland 3
Prescot 3
Pune 3
Redwood City 3
Rovato 3
Tokyo 3
Vienna 3
Baku 2
Bangkok 2
Totale 7.024
Salva come PNG Salva come JPEG
Nome #
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 165
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 163
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 159
COVID-19 impact on consecutive neurological patients admitted to the emergency department 148
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 146
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 145
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 132
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases 130
Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study 127
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 122
Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease 120
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 120
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 119
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 118
Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts 116
Vascular risk factors and cognition in Parkinson's disease 116
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 116
Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions 112
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 112
Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria 112
Microarray gene and miRNA expression studies: Looking for new therapeutic targets for frontotemporal lobar degeneration 111
Reply to the Letter " Covid-19-associated encephalopathy and cytokine-mediated Neuroinflammation" 111
Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs 109
Autonomic dysfunction in subjects at high risk for Parkinson’s disease 107
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. 106
Overlap between frontotemporal dementia and alzheimer's disease: Cerebrospinal fluid pattern and neuroimaging study 106
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease 105
Association between cognitive impairment and urinary dysfunction in Parkinson’s disease 105
Clinical, biological, and imaging features of monogenic Alzheimer's Disease. 104
A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term all-cause mortality in older hospitalized patients with transient ischemic attack 102
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 101
Functional genetic variation in the serotonin 5-HTTLPR modulates brain damage in frontotemporal dementia. 101
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study. 101
Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life. 100
Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment 99
Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study 98
Verbal memory declines more in female patients with Parkinson's disease: The importance of gender-corrected normative data 98
Disease-modifying therapies in frontotemporal lobar degeneration. 97
GBA-associated parkinsonism and dementia: Beyond α-synucleinopathies? 97
TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia. 95
Developments in the Role of Transcranial Sonography for the Differential Diagnosis of Parkinsonism 95
Pharmacogenetics of cytochrome P450 (CYP) in the elderly 95
In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody 94
Central serous chorioretinopathy: Pathogenesis and management 94
Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with parkinson's disease 93
FOXP2, APOE, and PRNP: new modulators in primary progressive aphasia. 90
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles 89
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 89
Impulse control disorder in PD: A lateralized monoaminergic frontostriatal disconnection syndrome? 87
Erratum: Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases (Neuron (2016) 91(1) (56–66)(S0896627316301970)(10.1016/j.neuron.2016.05.018)) 87
Brain glucose metabolism in Lewy body dementia: Implications for diagnostic criteria 87
Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson’s disease 87
Metabolic patterns across core features in dementia with lewy bodies 85
Brain-area specific white matter hyperintensities: Associations to falls in Parkinson's disease 81
null 77
Impaired metabolic brain networks associated with neurotransmission systems in the α-synuclein spectrum 77
Third ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson's disease 76
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study 72
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 70
Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension 67
Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism 65
Struktureller Ultraschall des medialen Temporallappens bei Alzheimer-Demenz 64
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 55
Design and test of an autonomous reconfigurable dynamic investigation test-rig on haptics (ARDITA) for pre-screening of the peripheral neuropathy diseases 53
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 52
Plasma Cystatin C correlates with plasma NfL levels and predicts disease progression in Parkinson's disease 52
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 51
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 51
Association of hippocampal subfields, CSF biomarkers and cognition in non-demented Parkinson's disease patients 50
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 49
Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study 49
Steroid-Responsive Encephalitis in Coronavirus Disease 2019 49
Long-term neurological manifestations of COVID-19: prevalence and predictive factors 49
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease 48
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 47
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 44
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET 43
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 43
Effects of COVID-19 outbreak on stroke admissions in Brescia, Lombardy, Italy 42
Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection 42
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 42
The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies 41
Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European-DLB consortium project 41
Plasma neurofilament light chain predicts cognitive progression in prodromal and clinical dementia with lewy bodies 39
Association of Plasma p-tau181 and p-tau231 Concentrations with Cognitive Decline in Patients with Probable Dementia with Lewy Bodies 39
NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients 38
Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential 38
Orthostatic hypotension and REM sleep behaviour disorder: Impact on clinical outcomes in α-synucleinopathies 38
CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies 37
Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: Results of NMR metabolomics investigation 35
Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies 35
Response to Abboud 35
Long-term unsupervised mobility assessment in movement disorders 34
Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile 34
Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions 34
Digital assessment at home — mPower against Parkinson disease 34
Motor, cognitive and mobility deficits in 1000 geriatric patients: protocol of a quantitative observational study before and after routine clinical geriatric treatment - The ComOn-study 33
Vortioxetine for the treatment of depressive episodes associated with Parkinson's disease: A case series of six patients 33
Gender-Related Vulnerability of Dopaminergic Neural Networks in Parkinson's Disease 33
In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases 33
Totale 8.067
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.801
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.801
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.156 0 0 0 0 0 228 213 211 152 218 48 86
2020/20211.874 17 263 106 171 180 261 117 148 162 200 152 97
2021/2022992 98 120 36 54 35 57 45 76 58 90 83 240
2022/2023794 135 23 9 27 74 216 12 63 115 16 54 50
2023/20241.220 80 20 105 61 58 231 47 42 295 23 48 210
2024/20251.289 56 26 47 515 394 251 0 0 0 0 0 0
Totale 9.515